NCT03140631View on ClinicalTrials.gov

Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

March 23, 2017

Primary Completion Date

November 16, 2017

Study Completion Date

April 3, 2018

Conditions
Atrial FibrillationCatheter Ablation
Interventions
DRUG

Protamine Sulfate

Protamine sulfate is a highly basic protein that forms stable compounds with acidic heparin to rapidly neutralize the anticoagulation effects.

Trial Locations (1)

48109

Michigan Medicine, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT03140631 - Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation | Biotech Hunter | Biotech Hunter